文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性患者房水蛋白质组分析

Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该研究对年龄和性别匹配的10例新生血管性AMD患者和10例对照的房水进行无标记定量蛋白质组学分析,鉴定出674种蛋白质,其中239种上调和86种下调,功能富集于血小板脱颗粒和补体/凝血级联等通路;ELISA验证显示Clusterin和Serpin A4差异表达,Clusterin区分AMD的AUC为0.82。

要点

  • 房水蛋白质组学鉴定出674种蛋白质,AMD中239种上调和86种下调。
  • 上调蛋白富集于血小板脱颗粒、补体/凝血级联等功能簇。
  • ELISA验证Clusterin和Serpin A4差异表达,Clusterin区分AMD的AUC为0.82。

核心结论

  • AMD患者房水蛋白质组存在多种蛋白质和功能簇表达改变,Clusterin等可能作为生物标志物或治疗靶点。

研究设计与样本

  • 年龄和性别匹配的新生血管性AMD患者(n=10)与对照(n=10)房水混合样本,进行无标记定量蛋白质组学(MS1)分析。
  • 验证集包括20例对照、15例萎缩性AMD和15例新生血管性AMD,通过多重ELISA检测9种差异表达蛋白质。

主要发现

  • MS1鉴定房水中674种蛋白质,其中239种在nvAMD中上调(nvAMD/对照>2,肽段标签>2),86种下调(nvAMD/对照<0.5,肽段标签>2)。
  • 上调蛋白质功能富集于血小板脱颗粒(富集分数28.1)、内肽酶活性负调控(18.8)、细胞蛋白质代谢过程(11.8)、表皮生长因子样结构域(10.3)、sushi/SCR/CCP(10.1)和补体/凝血级联(9.2)。
  • AMD蛋白质簇中3/6上调(χ2<0.05,与随机化比较)。
  • ELISA验证9种蛋白质中2种(Clusterin和Serpin A4,P<0.05)与MS1结果一致,3种(Clusterin、Serpin A4和TF,P<0.05)在萎缩性AMD和nvAMD之间差异表达。
  • ROC曲线计算显示Clusterin区分AMD的曲线下面积为0.82。

关键数值与推荐

  • 上调标准:nvAMD/对照>2且肽段标签>2;下调标准:nvAMD/对照<0.5且肽段标签>2。
  • 富集分数:血小板脱颗粒28.1,内肽酶活性负调控18.8,细胞蛋白质代谢过程11.8,表皮生长因子样结构域10.3,sushi/SCR/CCP 10.1,补体/凝血级联9.2。
  • ELISA验证差异表达显著性P<0.05;Clusterin作为AMD区分标志物的AUC为0.82。

临床怎么用

  • 房水蛋白质组学可无创获取样本,Clusterin等差异蛋白有潜力辅助AMD诊断或作为治疗靶点,但需进一步验证。

局限性

  • MS1分析基于混合房水样本,可能掩盖个体间差异。
  • ELISA验证的9种蛋白质中仅2种与MS1结果一致,验证率有限。
  • 样本量较小,需更大规模研究确认候选标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Age-related macular degeneration (AMD) is associated with altered gene and protein expression in the retina. We characterize the aqueous humor (AH) proteome in AMD to gain insight into the pathogenesis of the disease and identify potential biomarkers. METHODS: AH was collected from age and gender matched neovascular AMD (nvAMD; n = 10) patients and controls (n = 10). AH was pooled to create two samples (nvAMD and control), followed by intensity-based label-free quantification (MS1). Functional and bioinformatic analysis were then performed. A validation set (20 controls, 15 atrophic AMD and 15 nvAMD) was tested via multiplex ELISA for nine differentially expressed proteins according to the MS1 findings. RESULTS: MS1 identified 674 proteins in the AH. 239 proteins were upregulated in nvAMD (nvAMD/control > 2, peptide tags (PT) > 2), and 86 proteins were downregulated (nvAMD/control < 0.5, PT > 2). Functional analysis of proteins upregulated in AMD demonstrated enrichment for platelet degranulation (enrichment score (ES):28.1), negative regulation of endopeptidase activity (ES:18.8), cellular protein metabolic process (ES:11.8), epidermal growth factor-like domain (ES:10.3), sushi/SCR/CCP (ES:10.1), and complement/coagulation cascades (ES:9.2). AMD protein clusters were upregulated for 3/6 (χ2 < 0.05 compared to randomization). Validation via ELISA confirmed MS1 in 2/9 proteins (Clusterin and Serpin A4, P < 0.05), while 3/9 showed differential expression between aAMD and nvAMD (Clusterin, Serpin A4, and TF P < 0.05). Receiver operating characteristic curve calculation identified the area under the curve of 0.82 for clusterin as a biomarker for distinction of AMD. CONCLUSIONS: AH proteomics in AMD patients identified several proteins and functional clusters with altered expression. Further research should confirm if these proteins may serve as biomarkers or therapeutic target for the disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Rinsky B, Beykin G, Grunin M, et al. Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2021. PMID: 34406330. doi:10.1167/iovs.62.10.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。